Cord Blood America CEO Matthew Schissler was featured on Money TV, a widely watched television program. MoneyTV is broadcasted to 70 million in the U.S. and 45 million in Western Europe. On the show, he spoke of recent breakthroughs regarding the use of stem cells to treat diabetes.
Cord Blood has accomplished many of its goals this year. Operational loss was decreased 145%, revenues were increased 208%, basic and diluted loss per share was halved, and it reported record gross profits.
The company is focused on running its own cash flow and using monetary debt to finance new acquisitions. In a recent letter to shareholders, the CEO stated, “I have to believe that if we able to post an extraordinary track record, the stock price will reflect our achievements.”
Let us hear your thoughts below: